Cingulate Inc.
CING- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001862150
No open-market purchases or sales by Cingulate Inc. insiders were filed in the last 90 days; 32 institutions reported holding it in 13F filings for Q2 2026, worth $9.88M in total; no superinvestor holds it.
Other share classesCINGW
Q4 2025 vs. Q3 2025
How the institutions holding Cingulate Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 12 | 18 | +6 |
| Shares | 290.3K | 513.4K | +223.0K (+76.8%) |
| Value | $1.14M | $2.23M | +$1.09M (+95.8%) |
New holders (7)
Institutions that held Cingulate Inc. at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| DRW Securities, LLC | 58,672 | $254.6K | 0.02% |
| XTX Topco Ltd | 20,742 | $90.0K | 0.00% |
| Quadrature Capital Ltd | 15,182 | $65.9K | 0.00% |
| Soltis Investment Advisors LLC | 10,000 | $43.4K | 0.00% |
| Morgan Stanley | 1,000 | $4.34K | 0.00% |
| Tower Research Capital LLC (TRC) | 871 | $3.78K | 0.00% |
| SHP Wealth Management | 43 | $188 | 0.00% |
Sold out (1)
Institutions that held Cingulate Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Virtu Financial LLC | 10,772 | $42.0K |